Clinical Trial Update: Standard Versus Prolonged-release Tacrolimus Monotherapy After Alemtuzumab Induction in Kidney Transplantation [Phase 4]

View source ↗

Summary

Phase 4 trial comparing standard versus prolonged-release tacrolimus monotherapy after alemtuzumab induction in kidney transplantation has completed with posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Failure
• Graft Rejection

Drugs mentioned

• Alemtuzumab (Alemtuzumab)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Imperial College Healthcare NHS Trust | Conditions: End-stage Renal Failure, Graft Rejection | Phase 4 | Status: COMPLETED | Results posted: 2021-08-27